Continuous glucose monitors (CGMs) or flash glucose monitors : For adults with type 2 diabetes, eligibility is outlined in NICE guidance (NG28) and local NHS commissioning policies
In effect, bench scientists and data scientists at different locations can leverage the same underlying AI platform
About Wegovy (semaglutide injection) 1 Health Canada approved Wegovy in 2021 as a once-weekly treatment for Canadians living with obesity, supported by the efficacy and safety data from the STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial program
Weight Management Board-certified physician supporting medical weight loss alongside the behavioral and appetite factors that drive it
This physiological response helps prevent hypoglycaemia, a significant advantage over some other diabetes treatments
If the cause of a persons B12 deficiency is their diet, they may not require further shots or only require them once or twice per year